Biotech

All Articles

Daiichi spends Merck $170M to develop lung cancer cells T-cell engager contract

.Merck &amp Co. has actually swiftly recovered a number of the costs of its own Harpoon Rehabs buyou...

BioMarin stops preclinical gene therapy for heart condition

.After BioMarin carried out a spring well-maintained of its pipeline in April, the business has chos...

Eisai vegetations molecular adhesive SEED with $1.5 B biobucks work

.Huge Pharmas continue to be stuck to the tip of molecular glue degraders. The most up to date compa...

Life scientific research debt organization unveils with $600M

.A brand-new worldwide life scientific research credit scores firm, referred to as Symbiotic Resourc...

BMS ditches TIGIT, leaving $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing another huge bet from the Caforio time, terminating a deal f...

Nuvation halts BET prevention after looking at phase 1 information

.After looking at stage 1 data, Nuvation Biography has decided to halt focus on its own single lead ...

' Scientific intuitiveness' led FDA consultants to support Zevra's rare disease med

.Zevra Therapeutics' uncommon condition medicine appears to become on the path to permission this fa...

Pfizer takes $230M hit after axing neglected DMD genetics therapy

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) genetics therapy failure has actually gone a $23...

AC Immune observes 'spots' potential in Alzheimer's medicine records

.After greater than twenty years of deal with neurodegenerative diseases, Swiss biotech a/c Immune s...

GSK goes down ph. 2 HPV vaccine over shortage of best-in-class prospective

.GSK has actually junked a stage 2 human papillomavirus (HPV) vaccination coming from its pipeline a...